FONT2 was a clinical research study looking at whether Humira or Galactose can safely lower urine protein and protect kidney function better than standard treatment for patients with resistant FSGS. The treatment phase of the study lasted 6 months.
- 1 - 65 years old
- Steroid resistant or intolerant
- Not a transplant recipient
- Kidney function (eGFR >40 mL/min)
For more information please see our website:
Emily Herreshoff, CCRP
Phone: (734) 232-4852